the prestigious ECNP Neuropsychopharmacology Award in Clinical Science Research will tell the discovery story of the endocannabinoid system. His research has not only helped us to advance our understanding of cannabis use and its effects, but has also made key contributions with regard to understanding neuroprotection and has opened the door for the development of new drugs.
- The influence of opioid receptors in the brain:
The opioid system controls pain, reward and addictive behaviour. Brigitte Kieffer presents exciting new methods that now allow to understand how molecules act in the brain and control behaviour.
- Computerised training of working memory is a promising therapeutic strategy in ADHD:
ADHD is an increasingly frequent complex mental disorder in children with partly devastating consequences for the childs further development and the families. Torkel Klingberg presents new and very promising strategies of research to develop more appropriate treatments that specifically refer to the patients basic neuropsychological dysfunctions and mechanisms.
Invitation: Meet the scientists!
All the experts of the above listed themes will be available for questions by journalists in the course of topic specific press conferences on Sunday, Monday and Tuesday afternoon. You will find a detailed schedule of the press conferences in the enclosed Press information and procedures.
In addition, cutting edge research findings in the fields of Depression, Bipolar Affective Disorders, Schizophrenia, Anxiety Disorders, Obsessive Compulsive Disorder, Addiction and Basic Neuroscience will be presented in plenary lectures, educational updates and symposia, taking into account genetically related approaches as well as gender-specific aspects. Emphasis is placed on clear take-home-messages that can easily be transposed into clinical practice by medical professionals.
Due to the growing influenPage: 1 2 3 4 Related biology news :1
. New results validating Pall prion reduction filter disclosed at ISBT Congress